JIDEYTRO

Product NDC
85001-102
Requested package NDC
85001-102-01
11-digit product format
850010102
Labeler code
85001
Product ID
85001-102_6c672099-2978-474e-b783-973fe94efcfb
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
zidesamtinib
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Nuvalent, Inc.
Application
NDA220185
Marketing category
NDA
Marketing start
2026-07-22
Substance
ZIDESAMTINIB
Active strength
100 mg/1
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N220185-001JIDEYTROZIDESAMTINIB25MGTABLET / ORALRLD2026-07-22
N220185-002JIDEYTROZIDESAMTINIB100MGTABLET / ORALRLD, RS2026-07-22

Orange Book patents#

Current patent rows page 1 of 1 · 8 matching rows.

Application-product, Patent, Expiration table
Application-productPatentExpirationUse codeCoverage / statusSubmission date
N220185-001115422782041-05-05Drug substance, Drug product2026-07-30
N220185-001120544982041-05-05U-45792026-07-30
N220185-001120436262042-09-30Drug substance, Drug product2026-07-30
N220185-001126305602042-09-30U-45792026-07-30
N220185-002115422782041-05-05Drug substance, Drug product2026-07-30
N220185-002120544982041-05-05U-45792026-07-30
N220185-002120436262042-09-30Drug substance, Drug product2026-07-30
N220185-002126305602042-09-30U-45792026-07-30

Orange Book exclusivity#

Current exclusivity rows page 1 of 1 · 2 matching rows.

Application-product, Exclusivity code, Expiration table
Application-productExclusivity codeExpiration
N220185-001NCE2031-07-22
N220185-002NCE2031-07-22

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08N220185-001JIDEYTRO25MGTABLET / ORALRLD2026-07-2284e616aacf4f…
2026-09-14 22:38:342026-08N220185-002JIDEYTRO100MGTABLET / ORALRLD, RS2026-07-2284e616aacf4f…
2026-08-18 06:07:402026-07N220185-001JIDEYTRO25MGTABLET / ORALRLD2026-07-22caaa826d4ba7…
2026-08-18 06:07:402026-07N220185-002JIDEYTRO100MGTABLET / ORALRLD, RS2026-07-22caaa826d4ba7…

Observed Orange Book patent history#

Captured, Edition, Application-product table
CapturedEditionApplication-productPatentExpirationUse codeCoverage / statusSubmission dateSource SHA-256
2026-09-14 22:38:342026-08N220185-001115422782041-05-05Drug substance, Drug product2026-07-3084e616aacf4f…
2026-09-14 22:38:342026-08N220185-001120544982041-05-05U-45792026-07-3084e616aacf4f…
2026-09-14 22:38:342026-08N220185-001120436262042-09-30Drug substance, Drug product2026-07-3084e616aacf4f…
2026-09-14 22:38:342026-08N220185-001126305602042-09-30U-45792026-07-3084e616aacf4f…
2026-09-14 22:38:342026-08N220185-002115422782041-05-05Drug substance, Drug product2026-07-3084e616aacf4f…
2026-09-14 22:38:342026-08N220185-002120544982041-05-05U-45792026-07-3084e616aacf4f…
2026-09-14 22:38:342026-08N220185-002120436262042-09-30Drug substance, Drug product2026-07-3084e616aacf4f…
2026-09-14 22:38:342026-08N220185-002126305602042-09-30U-45792026-07-3084e616aacf4f…
2026-08-18 06:07:402026-07N220185-001115422782041-05-05Drug substance, Drug product2026-07-30caaa826d4ba7…
2026-08-18 06:07:402026-07N220185-001120544982041-05-05U-45792026-07-30caaa826d4ba7…
2026-08-18 06:07:402026-07N220185-001120436262042-09-30Drug substance, Drug product2026-07-30caaa826d4ba7…
2026-08-18 06:07:402026-07N220185-001126305602042-09-30U-45792026-07-30caaa826d4ba7…
2026-08-18 06:07:402026-07N220185-002115422782041-05-05Drug substance, Drug product2026-07-30caaa826d4ba7…
2026-08-18 06:07:402026-07N220185-002120544982041-05-05U-45792026-07-30caaa826d4ba7…
2026-08-18 06:07:402026-07N220185-002120436262042-09-30Drug substance, Drug product2026-07-30caaa826d4ba7…
2026-08-18 06:07:402026-07N220185-002126305602042-09-30U-45792026-07-30caaa826d4ba7…

Observed Orange Book exclusivity history#

Captured, Edition, Application-product table
CapturedEditionApplication-productExclusivity codeExpirationSource SHA-256
2026-09-14 22:38:342026-08N220185-001NCE2031-07-2284e616aacf4f…
2026-09-14 22:38:342026-08N220185-002NCE2031-07-2284e616aacf4f…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
JIDEYTRO
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
ZIDESAMTINIB100 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
MX5KQV5XHCInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 4 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
2748288Internal RxNorm lookup
2748294Internal RxNorm lookup
2748296Internal RxNorm lookup
2748298Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
3760e421-b523-4d9b-e063-6394a90ab94bAvailable on FDA.report

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
JIDEYTROZIDESAMTINIBNuvalent, Inc.3760e421-b523-4d9b-e063-6394a90ab94b2026-07-22Warnings, Adverse reactionsExact identifier
application applno (NDA): 220185
application number: NDA220185
ndc (package): 85001-102-01
ndc (product): 85001-102
ndc11 (package): 85001010201

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
85001-102-01850010102011 BOTTLE in 1 CARTON (85001-102-01) / 30 TABLET, FILM COATED in 1 BOTTLE1 bottle2026-07-22NoNoCurrent